Immunexpress Sponsored Webinar - Challenges of Sepsis Diagnosis: Harnessing the Host Response
Join us to learn about some of Immunexpress' recent innovations. This recorded sponsored innovation webinar addresses the shortcomings of past and current sepsis clinical criteria in accurately capturing patients with critical illness due to infection. Presenters describe the current status of microbiologic methods and single peptide biomarker. A novel approach utilizing the host gene response to infection is presented.
This course was originally recorded on 3/31/20.
Nurses, physician assistants, physicians, emergency responders, physical therapists, patient care assistants, and other healthcare staff
At the end of the webinar, the learner should be able to:
- Restate the sensitivity and specificity of the clinical criteria of sepsis.
- Identify the current microbiologic and biomarkers used to diagnose sepsis.
- Explain a new method for diagnosing sepsis utilizing the host gene response.
Sepsis Alliance gratefully acknowledges the support provided by Immunexpress for this sponsor innovation webinar.
Steven P. LaRosa, MD
Staff Physician - Infectious Disease, Beth Israel Lahey Health System
Dr. Steven P. LaRosa graduated from Boston University School of Medicine. He completed his Internal Medicine Residency at the Cleveland Clinic and Infectious Disease Fellowship at Massachusetts General Hospital. He was the lead Clinical Research Physician at Eli Lilly for the PROWESS trial that led to the FDA approval of Xigris for severe sepsis. He returned to academia as the Director of the Ocean State Clinical Coordinating Center at Rhode Island Hospital. In this position, he partnered with industry sponsors in clinical development planning, protocol and case report form designing, site selection and training, medical monitoring, and data review for molecules and devices targeting severe infections. He currently serves on a number of Medical Advisory Boards, Clinical Trial Steering Committees, Endpoint Adjudication Committees, and Data Safety Monitoring Boards for experimental agents, devices, and diagnostics in Infectious Disease.
No continuing education credits are offered for this sponsored webinar.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.